LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2018

Feb 12, 2018

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK: 0001062822
Period of Report: 2017-12-31

Reporting Person: WADE JEFFREY L (EVP, Corp Adm Affairs and CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-12-15	Common Stock	G	1000	—	Disposed	49597	Direct